Copper Deficiency (Hypocupraemia): Symptoms, Causes, Myelopathy and Treatment

⚡ Quick Answer: Copper deficiency (hypocupraemia) is more common in clinical practice than most physicians realise. In the United States and Europe, the three most common causes are high-dose zinc supplementation (zinc induces intestinal metallothionein which traps copper and prevents its absorption), bariatric surgery, and malabsorption conditions including coeliac disease and Crohn’s disease. The hallmark clinical triad is a myelopathy indistinguishable from Vitamin B12 subacute combined degeneration, a normocytic or microcytic anaemia that does not respond to iron, and neutropenia. The adult RDA for copper is 900 mcg (0.9 mg) per day. Treatment is oral copper supplementation 2 mg daily, with the cause corrected simultaneously.

The Man Whose B12 Was Normal

He was 58 years old. Progressive difficulty walking for two years. His gait had become uncertain and wide-based. He was dropping objects. His hands were clumsy. He had fallen twice in the past three months.

A neurologist reviewed him and documented loss of vibration sense in both feet, absent ankle reflexes, a positive Romberg sign, and brisk knee reflexes with upgoing plantar responses. The picture was classic posterior and lateral column involvement. Subacute combined degeneration of the spinal cord.

The team checked Vitamin B12. It was 310 pg/mL. Normal.

They checked it again with a methylmalonic acid (MMA) level. Also normal.

The patient was admitted to neurology. MRI of the cervical and thoracic spine showed the characteristic posterior column signal changes seen in B12 myelopathy. But the B12 was unequivocally normal.

A junior doctor remembered reading about copper deficiency myelopathy during a recent journal review. Serum copper was checked. It was 42 µg/dL — profoundly low. Ceruloplasmin was undetectable.

When the history was reviewed more carefully, one detail had been missed in the initial clerking. For two years — exactly coinciding with the start of his neurological symptoms — he had been taking zinc acetate 150 mg daily. He had read online that high-dose zinc prevents viral infections. He had never been told that zinc at this dose depletes copper.

He was started on oral copper supplementation 2 mg daily and his zinc was stopped. Over eight months his gait partially improved. His vibration sense returned to his knees but not his feet. Some of the damage was irreversible.

🏥  From My Clinic: I now check serum copper in every patient with a myelopathy or peripheral neuropathy where B12 is normal or borderline. I also check it in every patient on long-term high-dose zinc supplements. Copper deficiency myelopathy is one of the most under-diagnosed neurological conditions in Western clinical practice. It is not rare. It is simply not thought of. For the complete guide to nutritional deficiency diseases, read: Nutritional Deficiency Diseases: The Complete Doctor’s Guide.

What Copper Does

Copper is an essential trace mineral that serves as a cofactor for at least eight critical enzymes in human physiology. The body contains approximately 100 to 150 mg of total copper, distributed primarily in skeletal muscle (approximately 38%), brain (approximately 11%), liver (approximately 15%), and bone. The liver is the primary organ of copper storage and metabolism.

The Eight Copper-Dependent Enzymes

Cytochrome c oxidase (Complex IV). The terminal enzyme of the mitochondrial electron transport chain. Copper is essential for the transfer of electrons to oxygen to generate ATP. Without adequate copper, aerobic energy production in every cell is impaired. This is why copper deficiency produces profound fatigue alongside its neurological and haematological consequences.

Superoxide dismutase (Cu/Zn-SOD). The primary antioxidant enzyme that neutralises the superoxide radical, converting it to hydrogen peroxide which is then disposed of by catalase. Copper deficiency impairs antioxidant defence in a way that parallels selenium deficiency (which impairs glutathione peroxidase). Both minerals protect cells from oxidative damage through different enzymatic routes.

Ceruloplasmin. The primary copper transport protein in plasma. But ceruloplasmin also functions as a ferroxidase — it oxidises ferrous iron (Fe²⁺) to ferric iron (Fe³⁺), which is required for iron to bind transferrin and be transported to developing red blood cells. Without ceruloplasmin, iron accumulates in tissues (particularly the liver and brain) but cannot be mobilised for haemoglobin synthesis. This is why copper deficiency produces an anaemia that does not respond to iron supplementation — the iron is present but trapped.

Lysyl oxidase. Catalyses the cross-linking of collagen and elastin fibres. This cross-linking gives connective tissue, blood vessel walls, and bone matrix their tensile strength. In copper deficiency, collagen and elastin are structurally weak. Blood vessels become fragile. Bones become brittle. In Menkes disease — the genetic form of copper deficiency — the characteristic tortuous, fragile arteries that develop reflect lysyl oxidase failure.

Dopamine beta-hydroxylase. Converts dopamine to norepinephrine. Copper deficiency impairs this conversion, reducing norepinephrine production. This is one mechanism by which copper deficiency produces neuropsychiatric symptoms including depression, anxiety, and autonomic dysfunction.

Tyrosinase. The enzyme required for melanin synthesis. Copper deficiency impairs melanin production, causing depigmentation of skin and hair. This is strikingly visible in Menkes disease, where the characteristic pale, kinky hair directly reflects tyrosinase failure from copper deficiency.

Peptidylglycine alpha-amidating monooxygenase (PAM). Required for the activation of many neuropeptides including vasopressin, oxytocin, and various GI hormones. PAM deficiency from copper insufficiency contributes to neurological and endocrine dysfunction.

Clotting factor activation. Copper participates in the synthesis of clotting factors. Copper deficiency can produce a mild bleeding tendency alongside the more prominent anaemia and neutropenia.

How Much Copper Do You Need Per Day

Table 1. Copper RDA and Tolerable Upper Intake Levels. Source: NIH ODS. The upper limit of 10 mg per day refers to all sources. Chronic intake above 10 mg per day causes hepatotoxicity and liver failure.

Copper Status in the United States and Europe

Dietary copper deficiency from food alone is uncommon in adults eating a varied US or EU diet. Oysters, beef liver, dark chocolate, nuts, and seeds provide ample copper in a mixed diet. NHANES data shows mean copper intakes in US adults of approximately 1.1 to 1.6 mg per day — above the RDA.

The clinically significant copper deficiency encountered in the US and EU almost always has a specific cause beyond inadequate dietary intake: zinc supplementation, malabsorption, bariatric surgery, or premature birth. This makes copper deficiency a condition of clinical contexts, not simply of dietary poverty.

Symptoms of Copper Deficiency

The symptoms of copper deficiency reflect its roles in haematopoiesis, neurological function, immune defence, and connective tissue maintenance. The presentation varies considerably depending on whether the deficiency is acute and severe (as in premature neonates receiving copper-free parenteral nutrition) or chronic and gradually progressive (as in adults with long-term zinc supplementation or post-bariatric malabsorption).

Table 2. Symptoms of copper deficiency. Sources: NIH ODS; NCBI StatPearls (2025); Merck Manual; Neurology (2024 Review).

The Copper Deficiency Myelopathy — The Diagnosis Physicians Miss

This is the most clinically significant and most commonly missed feature of copper deficiency in adult patients. It deserves its own detailed discussion because the consequences of missing it are severe and often irreversible.

Copper deficiency myelopathy affects the dorsal (posterior) columns and lateral corticospinal tracts of the spinal cord — exactly the same anatomical distribution as Vitamin B12 subacute combined degeneration. The clinical signs are therefore identical: loss of vibration sense beginning in the feet, impaired proprioception, positive Romberg sign, brisk deep tendon reflexes, and upgoing plantar responses (Babinski sign). MRI of the spine shows characteristic T2 hyperintensity in the posterior columns.

The single critical difference: the B12 level is normal.

When a patient presents with this clinical and radiological picture and B12 is normal or borderline, most neurologists will check MMA and homocysteine to confirm true B12 deficiency. If these are also normal, the diagnosis is unclear. Many patients at this point are labelled as having idiopathic myelopathy, degenerative spine disease, or multiple sclerosis — and the actual treatable cause goes unidentified for months or years.

The correct next step when B12 myelopathy is suspected but B12 is normal: check serum copper and ceruloplasmin. This single test takes minutes to order and dramatically changes the clinical trajectory for the patient whose copper is low.

💡  Clinical Insight: I have learned to think of copper deficiency and B12 deficiency as the two treatable causes of posterior column myelopathy in adults. When one is normal, always check the other. Do not stop at a normal B12. Do not stop at a normal copper. Check both simultaneously.

The Anaemia That Looks Like Iron Deficiency But Isn’t

The anaemia of copper deficiency is characteristically normocytic or microcytic with normal or elevated serum ferritin and transferrin saturation — the opposite of true iron deficiency where ferritin is low and transferrin saturation is reduced.

The mechanism: ceruloplasmin (a copper-dependent ferroxidase) is required to oxidise Fe²⁺ to Fe³⁺ so that iron can bind transferrin for transport to erythroid precursors in the bone marrow. Without ceruloplasmin activity, iron accumulates in tissues but cannot be mobilised for haemoglobin synthesis.

The practical consequence: a patient with copper deficiency anaemia who is given iron supplementation shows no improvement, because iron is not the limiting factor. It is already present. The limiting factor is the failure of copper-dependent iron transport.

When an anaemia does not respond to iron after 6 to 8 weeks of adequate supplementation, copper deficiency is on the differential. Check serum copper and ceruloplasmin alongside B12, folate, and riboflavin — all of which can cause anaemia resistant to iron therapy.

What Causes Copper Deficiency

Table 3. Causes of copper deficiency. Sources: NIH ODS; NCBI StatPearls (2025); Merck Manual; Neurology.

The Zinc-Copper Interaction — The Most Important Public Health Message

This interaction is the most clinically important aspect of copper deficiency in the contemporary US and EU context, and it is almost entirely unrecognised by the public.

The mechanism is well established in biochemistry. Zinc induces the synthesis of metallothionein in intestinal enterocytes. Metallothionein is a cysteine-rich protein with an extraordinarily high affinity for heavy metals — including both zinc and copper. When metallothionein is induced by zinc, dietary copper binds it tightly within intestinal cells. When those cells complete their 3 to 5 day lifespan and shed into the gut lumen, the copper bound within them is lost in the stool. None of it is absorbed.

The clinical consequence: a person taking zinc 150 mg daily is inducing enough metallothionein to trap essentially all dietary copper from the intestine. The process is silent. Symptoms of copper deficiency — anaemia, neutropenia, and eventually myelopathy — develop over months to years while the patient continues taking their zinc supplement in the belief that they are supporting their immune health.

In the United States, zinc supplements of 50 to 200 mg per tablet are widely sold without prescription and actively marketed for immune support. The recommended dietary allowance for zinc is 8 to 11 mg per day for adults. These supplements provide 5 to 18 times the RDA in a single daily tablet. Many patients combine multiple supplements that each contain zinc, inadvertently consuming 100 mg or more per day for extended periods.

The threshold for copper depletion: doses of zinc above approximately 50 mg per day taken consistently for months will deplete copper stores in most adults. The higher the dose and the longer the duration, the more severe the depletion.

The clinical rule: any adult taking zinc supplements above 25 to 30 mg per day chronically requires either copper co-supplementation (1 to 2 mg copper per 50 mg zinc) or regular monitoring of serum copper and ceruloplasmin. This rule is almost never communicated on zinc supplement labels or by the practitioners who recommend them.

Wilson disease (copper overload) is the opposite problem — ATP7B gene mutation causing copper accumulation rather than deficiency. It is not discussed in this article but is mentioned here to clarify: copper supplementation is contraindicated in Wilson disease patients.

Menkes Disease — The Fatal Genetic Form

Menkes disease is the most severe form of copper deficiency and represents the complete opposite end of the spectrum from dietary or drug-induced adult deficiency.

The gene affected is ATP7A, which encodes the copper-transporting ATPase responsible for moving copper from intestinal enterocytes into the portal circulation and for distributing copper within cells to copper-dependent enzymes. When ATP7A is mutated, copper cannot be exported from intestinal cells. It accumulates in the gut while the brain, liver, and every other organ is profoundly deprived.

The clinical presentation is distinctive and heartbreaking:

Kinky or steely hair (pili torti): The hair is sparse, brittle, and twisted under microscopy. This reflects failure of the disulfide bonds in keratin that require copper-dependent enzyme activity. The hair abnormality is a direct and pathognomonic physical sign.

Progressive neurological degeneration: Seizures, profound hypotonia, and rapid developmental regression beginning in the first weeks of life. The brain requires copper at every level of development and degenerates rapidly without it.

Connective tissue failure: Bladder diverticula, joint laxity, skin that is pale, loose, and doughy. The tortuous, fragile arteries produced by lysyl oxidase failure can rupture, causing subdural haematoma and stroke-like events.

Hypothermia: Copper-dependent thermogenesis fails.

Without treatment, Menkes disease is fatal, usually before the age of three. Early intravenous or subcutaneous copper histidine therapy, initiated before irreversible neurological damage has occurred (ideally within the first few weeks of life), can partially stabilise or improve the neurological outcome. Newborn screening programmes in some US states now include Menkes disease to enable this early intervention, though it is not universally screened.

Diagnosis

Copper deficiency is a laboratory diagnosis in most adult patients, confirmed by the combination of low serum copper and low ceruloplasmin in the appropriate clinical context.

Blood Tests

Serum copper: The primary diagnostic test. Reference range: 70 to 140 µg/dL (11 to 22 µmol/L) in most US and European laboratories. Below 70 µg/dL indicates deficiency. Below 50 µg/dL indicates severe deficiency.

Important caveat: serum copper is an acute-phase reactant. It rises during infection, inflammation, pregnancy, and oestrogen use (including the oral contraceptive pill). A patient with an inflammatory illness may have a falsely normal or even elevated serum copper despite true tissue copper depletion. Interpret results in the context of inflammatory markers (CRP, ESR).

Serum ceruloplasmin: The most clinically useful marker for copper status. Ceruloplasmin is synthesised in the liver and requires copper for its structure and function. It falls reliably in copper deficiency. Reference range: 20 to 35 mg/dL. Below 20 mg/dL indicates copper deficiency. Undetectable ceruloplasmin indicates severe deficiency or aceruloplasminaemia (a rare genetic condition).

Like serum copper, ceruloplasmin is also an acute-phase reactant — it rises in inflammation. Both must be interpreted together. Low ceruloplasmin in the context of elevated CRP is highly significant for true copper deficiency.

24-hour urine copper: Reflects copper excretion and helps assess body copper status and balance. In copper deficiency, urinary copper is typically very low (below 15 µg per 24 hours). Used alongside serum levels for complete assessment. Also useful in Wilson disease monitoring where it is elevated.

Complete blood count: Anaemia (normocytic or microcytic), neutropenia, and occasionally thrombocytopenia. The combination of anaemia plus neutropenia with normal or elevated serum ferritin strongly suggests copper deficiency.

Serum ferritin and iron studies: To confirm that the anaemia is not primary iron deficiency. In copper deficiency, ferritin is normal or elevated and transferrin saturation is normal, distinguishing it from iron deficiency anaemia.

Vitamin B12 and methylmalonic acid: Always check simultaneously with copper in any myelopathy workup. B12 myelopathy and copper myelopathy can coexist. Both must be addressed.

Serum zinc: Zinc excess drives copper depletion. In patients taking high-dose zinc, serum zinc may be elevated or normal but the history is the key diagnostic clue.

MRI spine: In patients with myelopathy, MRI of the cervical and thoracic spine shows characteristic T2 hyperintensity in the posterior columns — identical to B12 myelopathy and not distinguishable on imaging alone. The clinical laboratory values are what differentiate the two.

Bone marrow examination: If the diagnosis remains uncertain, bone marrow aspirate in copper deficiency shows characteristic vacuolation of myeloid and erythroid precursors — a morphological pattern that strongly suggests the diagnosis when present alongside low serum copper.

Treatment

Table 4. Copper deficiency treatment protocol. Sources: NIH ODS; NCBI StatPearls (2025); Merck Manual; Neurology.

Recovery Timeline

Table 5. Copper deficiency recovery timeline. Source: Clinical experience; NCBI StatPearls (2025); Neurology.

The critical message about the myelopathy: Neurological recovery from copper deficiency myelopathy is partial at best and often disappointing. The posterior column damage is structural and slow to regenerate. In most reported series, patients improve somewhat — gait becomes safer, vibration sense returns partially — but complete recovery is unusual. Early diagnosis, before significant structural cord damage has accumulated, is the only way to preserve full neurological function. This is why the clinical index of suspicion must be high in any patient with risk factors.

Best Food Sources of Copper

The copper content of food is highly variable. Animal organ meats — particularly beef liver and oysters — are by far the richest sources. Most plant foods contain moderate amounts of copper, with the notable exceptions of nuts, seeds, and dark chocolate.

Table 6. Top dietary sources of copper. Source: NIH ODS; USDA FoodData Central. Adult RDA: 900 mcg (0.9 mg) per day.

The zinc-copper dietary balance: The dietary ratio of zinc to copper matters as much as absolute intake of either mineral. The optimal dietary zinc-to-copper ratio is approximately 8 to 12:1. Most Western diets naturally provide this ratio when eaten as whole foods. The problem arises exclusively with supplementation at non-physiological doses. A person eating oysters, liver, dark chocolate, nuts, and seeds alongside their normal diet is not at risk of copper deficiency from food alone. The risk is entirely in the supplement context.

Related Articles on MedBeaconHub.com

• Nutritional Deficiency Diseases: The Complete Doctor’s Guide
• Zinc Deficiency: Immunity, Taste and the Copper Connection
• Vitamin B12 Deficiency: Nerve Damage and Pernicious Anaemia
• Iron Deficiency Anaemia: Symptoms and Treatmen
• Selenium Deficiency: The Thyroid and Mitochondrial Mineral
• Magnesium Deficiency: Sleep, Anxiety and Muscle Cramps
• Folate Deficiency: The Pregnancy-Critical B Vitamin
• Vitamin D Deficiency: The Most Common US Deficiency
• Calcium Deficiency: Hypocalcaemia and Bone Disease
• Vitamin B1 Thiamine Deficiency: Beriberi and Wernicke Encephalopathy
• Vitamin B2 Riboflavin Deficiency: Symptoms, Migraine and MTHFR
• Vitamin B3 Niacin Deficiency: Pellagra and the Four Ds
• Vitamin B6 Deficiency: Depression, Neuropathy and the OCP
• Vitamin A Deficiency: Night Blindness and Immunity
• Vitamin K Deficiency: Bleeding and Warfarin

References and Authoritative Sources

1. NIH Office of Dietary Supplements — Copper Fact Sheet for Health Professionals
2. NCBI StatPearls — Copper Deficiency (Updated 2025)
3. Merck Manual Professional Edition — Copper Deficiency
4. Cleveland Clinic — Copper Deficiency
5. Neurology — Copper Deficiency Myelopathy: A Systematic Review (2024)
6. American Journal of Clinical Nutrition — High-Dose Zinc Supplementation and Copper Status (2024)
7. PMC — Copper Deficiency After Bariatric Surgery: Systematic Review (2024)
8. Genetics in Medicine — Menkes Disease: Diagnosis, Management, and Outcomes (2023)
9. PMC — Copper Deficiency Myelopathy and Zinc Supplementation (2024)
10. NEJM — Copper Deficiency Myeloneuropathy (2023)